PENNSYLVANIA
|
|
No.
23-0993790
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
One
Quaker Park
901
Hector Street
Conshohocken,
Pennsylvania 19428
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
(610)
832-4000
|
(Registrant’s
telephone number, including area code)
|
|
(Former
name or former address, if changed since last
report)
|
Exhibit
No.
|
|
99.1
|
Press
Release of Quaker Chemical Corporation dated April 29, 2008.
|
QUAKER CHEMICAL CORPORATION | ||
Registrant | ||
Date:
April 30, 2008
|
By:
|
/s/
Mark A. Featherstone
|
|
|
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
|
NEWS
|
||
For
Release:
Immediate
|
Contact:
Mark
A. Featherstone
Vice
President and
Chief
Financial Officer
610-832-4160
|
|
|
Quaker
Chemical Corporation
|
|||||||
Condensed
Consolidated Statement of Income
|
|||||||
(Dollars
in thousands, except per share data and share
amounts)
|
|||||||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
(Unaudited)
|
|
||||
|
|
|
|
|
|
||
|
|
Three
Months Ended March 31,
|
|
||||
|
|
2008
|
|
2007
|
|||
Net
sales
|
$
|
147,718
|
$
|
124,891
|
|||
Cost
of goods sold
|
104,083
|
86,345
|
|||||
Gross
margin
|
43,635
|
38,546
|
|||||
%
|
29.5
|
%
|
30.9
|
%
|
|||
Selling,
general and administrative expenses
|
34,504
|
31,919
|
|||||
Operating
income
|
9,131
|
6,627
|
|||||
%
|
6.2
|
%
|
5.3
|
%
|
|||
Other
income, net
|
161
|
327
|
|||||
Interest
expense, net
|
(1,182
|
)
|
(1,350
|
)
|
|||
Income
before taxes
|
8,110
|
5,604
|
|||||
Taxes
on income
|
2,765
|
1,844
|
|||||
5,345
|
3,760
|
||||||
Equity
in net income of associated companies
|
112
|
125
|
|||||
Minority
interest in net income of subsidiaries
|
(364
|
)
|
(348
|
)
|
|||
Net
income
|
$
|
5,093
|
$
|
3,537
|
|||
%
|
3.4
|
%
|
2.8
|
%
|
|||
Per
share data:
|
|||||||
Net
income - basic
|
$
|
0.50
|
$
|
0.36
|
|||
Net
income - diluted
|
$
|
0.50
|
$
|
0.35
|
|||
Shares
Outstanding:
|
|||||||
Basic
|
10,085,859
|
9,907,683
|
|||||
Diluted
|
10,179,539
|
10,024,905
|
Quaker
Chemical Corporation
|
|||||||
Condensed
Consolidated Balance Sheet
|
|||||||
(Dollars
in thousands, except par value and share
amounts)
|
|||||||
|
|
|
|
|
|
||
|
|
(Unaudited)
|
|
||||
|
|
|
|
|
|
||
|
|
March
31,
|
|
December
31,
|
|
||
|
|
2008
|
|
2007
|
|||
ASSETS
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
20,527
|
$
|
20,195
|
|||
Accounts
receivable, net
|
120,273
|
118,135
|
|||||
Inventories,
net
|
64,559
|
60,738
|
|||||
Prepaid
expenses and other current assets
|
16,057
|
14,433
|
|||||
Total
current assets
|
221,416
|
213,501
|
|||||
Property,
plant and equipment, net
|
63,707
|
62,287
|
|||||
Goodwill
|
45,799
|
43,789
|
|||||
Other
intangible assets, net
|
7,668
|
7,873
|
|||||
Investments
in associated companies
|
7,959
|
7,323
|
|||||
Deferred
income taxes
|
32,018
|
30,257
|
|||||
Other
assets
|
40,476
|
34,019
|
|||||
Total
assets
|
$
|
419,043
|
$
|
399,049
|
|||
LIABILITIES
AND SHAREHOLDERS' EQUITY
|
|||||||
Current
liabilities
|
|||||||
Short-term
borrowings and current portion of long-term debt
|
$
|
3,875
|
$
|
4,288
|
|||
Accounts
and other payables
|
68,519
|
67,380
|
|||||
Accrued
compensation
|
9,730
|
17,287
|
|||||
Other
current liabilities
|
17,701
|
17,396
|
|||||
Total
current liabilities
|
99,825
|
106,351
|
|||||
Long-term
debt
|
89,235
|
78,487
|
|||||
Deferred
income taxes
|
8,209
|
7,583
|
|||||
Other
non-current liabilities
|
77,557
|
71,722
|
|||||
Total
liabilities
|
274,826
|
264,143
|
|||||
Minority
interest in equity of subsidiaries
|
4,750
|
4,513
|
|||||
Shareholders'
equity
|
|||||||
Common
stock, $1 par value; authorized 30,000,000 shares; issued 10,268,988
shares
|
10,269
|
10,147
|
|||||
Capital
in excess of par value
|
11,844
|
10,104
|
|||||
Retained
earnings
|
118,506
|
115,767
|
|||||
Accumulated
other comprehensive loss
|
(1,152
|
)
|
(5,625
|
)
|
|||
Total
shareholders' equity
|
139,467
|
130,393
|
|||||
Total
liabilities and shareholders' equity
|
$
|
419,043
|
$
|
399,049
|
Quaker
Chemical Corporation
|
|||||||
Condensed
Consolidated Statement of Cash Flows
|
|||||||
For
the Three months ended March 31,
|
|||||||
(Dollars
in thousands)
|
|||||||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
(Unaudited)
|
|
||||
|
|
2008
|
|
2007
|
|||
Cash
flows from operating activities
|
|||||||
Net
income
|
$
|
5,093
|
$
|
3,537
|
|||
Adjustments
to reconcile net income to net cash used in operating activities:
|
|||||||
Depreciation
|
2,680
|
2,719
|
|||||
Amortization
|
300
|
339
|
|||||
Equity
in net income of associated companies, net of dividends
|
(112
|
)
|
44
|
||||
Minority
interest in earnings of subsidiaries
|
364
|
348
|
|||||
Deferred
income tax
|
1,246
|
361
|
|||||
Deferred
compensation and other, net
|
22
|
267
|
|||||
Stock-based
compensation
|
376
|
262
|
|||||
(Gain)
Loss on disposal of property, plant and equipment
|
(35
|
)
|
5
|
||||
Insurance
settlement realized
|
(136
|
)
|
(265
|
)
|
|||
Pension
and other postretirement benefits
|
(2,458
|
)
|
(869
|
)
|
|||
Increase
(decrease) in cash from changes in current assets and current liabilities,
net of acquisitions:
|
|||||||
Accounts
receivable
|
1,159
|
(10,633
|
)
|
||||
Inventories
|
(2,374
|
)
|
(3,019
|
)
|
|||
Prepaid
expenses and other current assets
|
(3,037
|
)
|
(873
|
)
|
|||
Accounts
payable and accrued liabilities
|
(9,280
|
)
|
2,749
|
||||
Net
cash used in operating activities
|
(6,192
|
)
|
(5,028
|
)
|
|||
Cash
flows from investing activities
|
|||||||
Capital
expenditures
|
(1,949
|
)
|
(2,721
|
)
|
|||
Payments
related to acquisitions
|
(1,000
|
)
|
(1,000
|
)
|
|||
Proceeds
from disposition of assets
|
65
|
-
|
|||||
Insurance
settlement received and interest earned
|
5,112
|
143
|
|||||
Change
in restricted cash, net
|
(4,976
|
)
|
122
|
||||
Net
cash used in investing activities
|
(2,748
|
)
|
(3,456
|
)
|
|||
Cash
flows from financing activities
|
|||||||
Net
decrease in short-term borrowings
|
(378
|
)
|
(1,262
|
)
|
|||
Proceeds
from long-term debt
|
9,844
|
5,277
|
|||||
Repayments
of long-term debt
|
(251
|
)
|
(225
|
)
|
|||
Dividends
paid
|
(2,181
|
)
|
(2,137
|
)
|
|||
Stock
options exercised, other
|
1,486
|
1,809
|
|||||
Distributions
to minority shareholders
|
-
|
(270
|
)
|
||||
Net
cash provided by financing activities
|
8,520
|
3,192
|
|||||
Effect
of exchange rate changes on cash
|
752
|
17
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
332
|
(5,275
|
)
|
||||
Cash
and cash equivalents at the beginning of the period
|
20,195
|
16,062
|
|||||
Cash
and cash equivalents at the end of the period
|
$
|
20,527
|
$
|
10,787
|